Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | #NAME? |
| PDB ID | UniProt ID ▼ | Title | Descriptor |
|---|---|---|---|
| 7LAA | 7LAA | Structure of SARS-CoV-2 S protein in complex with Receptor Binding Domain antibody DH1041 | |
| 7LA8 | 7LA8 | O6 variable lymphocyte receptor ectodomain bound to 3-HSO3-Gal-4GlcNAc | |
| 7LA4 | 7LA4 | Integrin AlphaIIbBeta3-PT25-2 Complex | |
| 7L90 | 7L90 | BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-8 from animal Rh.33311 (Wk26 time point) | |
| 7L8Z | 7L8Z | BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-7 from animal Rh.33311 (Wk26 time point) | |
| 7L8Y | 7L8Y | BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-5 from animal Rh.33311 (Wk26 time point) | |
| 7L8X | 7L8X | BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-4 from animal Rh.33311 (Wk26 time point) | |
| 7L8W | 7L8W | BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-3 from animal Rh.33311 (Wk26 time point) | |
| 7L8U | 7L8U | BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-2 from animal Rh.33311 (Wk26 time point) | |
| 7L8T | 7L8T | BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-1 from animal Rh.33311 (Wk26 time point) | |
| 7L8S | 7L8S | BG505 SOSIP.v5.2(7S) in complex with the polyclonal Fab pAbC-4 from animal Rh.33172 (Wk38 time point) | |
| 7L8P | 7L8P | Integrin alphaIIbbeta3 in complex with sibrafiban | |
| 7L8G | 7L8G | BG505 SOSIP.v5.2(7S) in complex with the polyclonal Fab pAbC-3 from animal Rh.33172 (Wk38 time point) | |
| 7L8F | 7L8F | BG505 SOSIP.v5.2(7S) in complex with the polyclonal Fab pAbC-2 from animal Rh.33172 (Wk38 time point) | |
| 7L8E | 7L8E | BG505 SOSIP.v5.2(7S) in complex with the polyclonal Fab pAbC-1 from animal Rh.33172 (Wk38 time point) | |
| 7L8D | 7L8D | BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-4 from animal Rh.33104 (Wk26 time point) | |
| 7L8C | 7L8C | BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-3 from animal Rh.33104 (Wk26 time point) | |
| 7L8B | 7L8B | BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-2 from animal Rh.33104 (Wk26 time point) | |
| 7L8A | 7L8A | BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-1 from animal Rh.33104 (Wk26 time point) | |
| 7L89 | 7L89 | BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-4 from animal Rh.32034 (Wk26 time point) | |
| 7L88 | 7L88 | BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-3 from animal Rh.32034 (Wk26 time point) | |
| 7L87 | 7L87 | BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-2 from animal Rh.32034 (Wk26 time point) | |
| 7L86 | 7L86 | BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-1 from animal Rh.32034 (Wk26 time point) | |
| 7L7U | 7L7U | BG505 SOSIP reconstructed from a designed nanoparticle, BG505 SOSIP-T33-31 (Component B) | |
| 7L7T | 7L7T | BG505 SOSIP reconstructed from a designed nanoparticle, BG505 SOSIP-T33-31 (Component A) | |
| 7L7R | 7L7R | CCHFV Gc prefusion monomer bound to ADI-36121 and ADI-37801 Fabs | |
| 7L7E | 7L7E | Crystal structure of SARS-CoV-2 spike RBD in complex with human monoclonal antibodies AZD8895 and AZD1061 | |
| 7L7D | 7L7D | Crystal structure of SARS-CoV-2 spike RBD in complex with human monoclonal antibody AZD8895 | |
| 7L6O | 7L6O | Cryo-EM structure of HIV-1 Env CH848.3.D0949.10.17chim.6R.DS.SOSIP.664 | CH848.3.D0949.10.17chim.6R.DS.SOSIP.664 - gp120, CH848.3.D0949.10.17chim.6R.DS.SOSIP.664 - gp41 |
| 7L58 | 7L58 | Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab H4 | Spike glycoprotein, Fab H4 variable domain heavy chain, Fab H4 variable domain light chain |
| 7L57 | 7L57 | Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-15 | Spike glycoprotein, Fab 2-15 variable domain heavy chain, Fab 2-15 variable domain light chain |
| 7L56 | 7L56 | Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-43 | |
| 7L4Z | 7L4Z | Structure of SARS-CoV-2 spike RBD in complex with cyclic peptide | |
| 7L3N | 7L3N | SARS-CoV 2 Spike Protein bound to LY-CoV555 | Spike glycoprotein, LY-CoV555 Fab heavy chain, LY-CoV555 Fab light chain |
| 7L2F | 7L2F | Cryo-EM structure of NTD-directed neutralizing antibody 5-24 in complex with prefusion SARS-CoV-2 spike glycoprotein | |
| 7L2E | 7L2E | Cryo-EM structure of NTD-directed neutralizing antibody 4-18 in complex with prefusion SARS-CoV-2 spike glycoprotein | |
| 7L2D | 7L2D | Cryo-EM structure of NTD-directed neutralizing antibody 1-87 in complex with prefusion SARS-CoV-2 spike glycoprotein | SARS-CoV-2 spike glycoprotein, 1-87 heavy chain, 1-87 light chain |
| 7L2C | 7L2C | Crystallographic structure of neutralizing antibody 2-51 in complex with SARS-CoV-2 spike N-terminal domain (NTD) | |
| 7L1Y | 7L1Y | Unlocking the structural features for the exo-xylobiosidase activity of an unusual GH11 member identified in a compost-derived consortium-xylobiose complex | |
| 7L15 | 7L15 | Marsupial T cell receptor Spl_118 | |
| 7L0N | 7L0N | Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity | |
| 7L0L | 7L0L | Cryo-EM structure of the VRC316 clinical trial, vaccine-elicited, human antibody 316-310-1B11 in complex with an H2 CAN05 HA trimer | |
| 7L09 | 7L09 | Cryo-EM structure of SARS-CoV-2 2P S ectodomain bound domain-swapped antibody 2G12 from masked 3D refinement | 2G12 heavy chain, 2G12 light chain, Spike glycoprotein |
| 7L06 | 7L06 | Cryo-EM structure of SARS-CoV-2 2P S ectodomain bound to two copies of domain-swapped antibody 2G12 | 2G12 heavy chain, 2G12 light chain, Spike glycoprotein |
| 7L02 | 7L02 | Cryo-EM structure of SARS-CoV-2 2P S ectodomain bound to one copy of domain-swapped antibody 2G12 | 2G12 heavy chain, 2G12 light chain, Spike glycoprotein |
| 7KZB | 7KZB | Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1antibodies | |
| 7KXK | 7KXK | SARS-CoV-2 spike protein in complex with Fab 15033-7, 2-"up"-1-"down" conformation | |
| 7KXJ | 7KXJ | SARS-CoV-2 spike protein in complex with Fab 15033-7, 3-"up", asymmetric | |
| 7KWO | 7KWO | rFVIIIFc-VWF-XTEN (BIVV001) | Coagulation factor FVIII-Fc-XTEN, von Willebrand factor-XTEN-Fc |
| 7KTX | 7KTX | Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to a Fab in DDM detergent | Endoplasmic reticulum membrane protein complex subunit 10, ER membrane protein complex subunit 1, Protein SOP4, Fab DH4 light chain, ER membrane protein complex subunit 4, ER membrane protein complex subunit 2, ER membrane protein complex subunit 5, ER membrane protein complex subunit 3, ER membrane protein complex subunit 6, Fab DH4 heavy chain, Unassigned helix |
